Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Iowa City, IA
Education & Training
St Mary Medical CenterResidency, Internal Medicine, 2010 - 2013
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2010
Loyola University Medical CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2023 - 2025
IL State Medical License 2014 - 2023
MI State Medical License 2019 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker Start of enrollment: 2020 Jul 20
Publications & Presentations
PubMed
- 175 citationsAnti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximabJulie A. Bowles, Siao-Yi Wang, Brian K. Link, Allan Barrett W, Gregory Beuerlein
Blood. 2005-11-16 - 140 citationsNK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complementSiao-Yi Wang, Emilian Racila, Ronald P. Taylor, George J. Weiner
Blood. 2008-02-01 - 58 citationsComplement and cellular cytotoxicity in antibody therapy of cancer.Siao-Yi Wang, George J. Weiner
Expert Opinion on Biological Therapy. 2008-05-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
